Clopidogrel Bisulphate IP 75 mg + Aspirin IP (EC) 150 mg (Hard Gelatin) Capsules

Clopidogrel Bisulphate IP 75 mg + Aspirin IP (EC) 150 mg (Hard Gelatin) Capsules is a hard gelatin capsule formulated with Clopidogrel Bisulphate IP 75 mg + Aspirin IP (EC) 150 mg ( ). The listed active ingredient profile is Clopidogrel Bisulphate; Aspirin, placing the product in the cardiovascular category. The formulation contains cardiovascular medicines used for approved vascular, lipid or antiplatelet indications. The source identifies the dosage form as hard gelatin capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.